In October 2020, PhRMA added a new chapter on Enhancing Diversity in Clinical Trial Participation its Principles on Conduct in Clinical Trials.  With this addition, PhRMA member companies commit to continuing to work with patients, patient advocacy groups, regulatory authorities, healthcare practitioners, academics, and policymakers to define the systematic and impactful approaches that we will take to enhance the diversity of clinical trial participants and help reduce healthcare disparities.

Read the Executive Summary of the Principles here.